RE:New Press Release - Sirona Biochem Receives Antiviral Testing ResultsNot spot on in the first trial, but might be successful next time.
Producing new compunds is part of daily dirt so I don't think the work will generate any extra costs worth considering. Of course the allocation of resources will prohibit other research, but short term it seems like a balanced descision. The cost at the partner is unknown, but based on the partner description it should be affordable.
Anti-viral would be a nice bonus. Short term we need a successful anti-aging clinical trial to kick off positive expectations as well as any diabetes deal that generate revenue. I'm waiting...